Product Code: SR1323A301_Report
The global dry eye syndrome market size reached US$ 4.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.67% during 2023-2028.
Dry eye syndrome, medically known as keratoconjunctivitis sicca (KCS), is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a commonly occurring disease which can affect almost anyone. Various symptoms of dry eye include aching and burning sensations, sore eyes, red eyes, fatigued eyes, itchy eyes, photophobia, etc. Apart from this, watery eyes can also be a symptom as the dry surface of the eyes over-stimulate the production of watery component of tears in order to reduce the dryness. There are several factors that can cause dry eye syndrome such as excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.
Various diseases, such as diabetes, thyroid disorders, Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, etc., are also contributing to the prevalence of dry eyes among people. As per statistics, around 425-430 Million individuals across the globe get affected by diabetes. It causes constant changes in the composition of patient's blood which adversely affects the tear glands resulting in a rising prevalence of dry eye. Another key factor which is contributing to the growth of the market is the rising geriatric population. As per estimates, around 9% of the global population is above 65 years of age, and by 2050 this segment is expected to account for around 17% of the global population. With the prevalence of dry eyes being high among the elderly, we expect the market for dry eye syndrome to exhibit a strong growth. Other factors augmenting the growth of this market include increasing awareness levels, rising diagnostic rates, better treatment options, etc.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global dry eye syndrome market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
- Evaporative
- Aqueous
- Based on the disease type, evaporative dry eye syndrome currently accounts for the highest market share.
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
- Based on the drug type, anti-inflammatory drugs currently account for the highest market share.
Breakup by Product:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
- Based on the product type, liquid eye drops currently account for the highest market share.
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Based on the distribution channel, hospital pharmacies currently account for the highest market share.
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
- On the geographical front, North America currently represents the biggest market for dry eye syndrome.
Competitive Landscape:
- The competitive landscape of the market has also been examined with some of the key players being, Akorn Operating Company LLC, Alimera Science, Allergan plc., Auven Therapeutics, Bausch + Lomb Incorporated, GlaxoSmithKline plc, Nicox S.A., Novartis AG, Otsuka Holdings Co. Ltd., and Santen Pharmaceutical Co. Ltd.
Key Questions Answered in This Report:
- 1. What was the size of the global dry eye syndrome market in 2022?
- 2. What is the expected growth rate of the global dry eye syndrome market during 2023-2028?
- 3. What are the key factors driving the global dry eye syndrome market?
- 4. What has been the impact of COVID-19 on the global dry eye syndrome market?
- 5. What is the breakup of the global dry eye syndrome market based on the disease type?
- 6. What is the breakup of the global dry eye syndrome market based on the drug type?
- 7. What is the breakup of the global dry eye syndrome market based on the product?
- 8. What is the breakup of the global dry eye syndrome market based on the distribution channel?
- 9. What are the key regions in the global dry eye syndrome market?
- 10. Who are the key companies/players in the global dry eye syndrome market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Dry Eye Syndrome Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Disease Type
- 5.5 Market Breakup by Drug Type
- 5.6 Market Breakup by Product
- 5.7 Market Breakup by Distribution Channels
- 5.8 Market Breakup by Region
- 5.9 Market Forecast
6 Market Breakup by Disease Type
- 6.1 Evaporative Dry Eye Syndrome
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Aqueous Dry Eye Syndrome
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Anti-inflammatory Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Lubricant Eye Drops
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Autologous Serum Eye Drops
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Product
- 8.1 Liquid Drops
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Gel
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Liquid Wipes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Eye Ointment
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Europe
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Asia Pacific
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Middle East and Africa
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Latin America
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
11 Global Dry Eye Syndrome Industry: SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Global Dry Eye Syndrome Industry: Value Chain Analysis
13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Global Dry Eye Syndrome Industry: Price Analysis
- 14.1 Price Indicators
- 14.2 Price Structure
- 14.3 Margin Analysis
15 Manufacturing Process
- 15.1 Product Overview
- 15.2 Raw Material Requirements
- 15.3 Manufacturing Process
- 15.4 Key Success and Risk Factors
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Akorn Operating Company LLC
- 16.3.2 Alimera Science
- 16.3.3 Allergan plc.
- 16.3.4 Auven Therapeutics
- 16.3.5 Bausch + Lomb Incorporated
- 16.3.6 GlaxoSmithKline plc
- 16.3.7 Nicox S.A.
- 16.3.8 Novartis AG
- 16.3.9 Otsuka Holdings Co., Ltd.
- 16.3.10 Santen Pharmaceutical Co., Ltd.